ZVRA
ZEVRA THERAPEUTICS, INC.
Key Financials
Net Income
$83.2M
↑ 178.9%
Revenue
$0
NaN%
Operating Income
$-62943000
↑ 27.7%
EPS (Diluted)
$1.35
↑ 159.2%
Total Liabilities
$130.1M
↓ 6.1%
Shareholders' Equity
$154.7M
↑ 289.9%
Cash & Equivalents
$62.4M
↑ 84.7%
Long-term Debt
$61.9M
↑ 4.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/5/2026 | View on SEC |
| 4 | 5/29/2026 | View on SEC |
| 4 | 5/13/2026 | View on SEC |
| 144 | 5/11/2026 | View on SEC |
| 10-Q | 5/6/2026 | View on SEC |
| 8-K | 5/6/2026 | View on SEC |
| SCHEDULE 13G | 5/6/2026 | View on SEC |
| DEF 14A | 4/20/2026 | View on SEC |
| PRE 14A | 4/6/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ZVRA |
| Company Name | ZEVRA THERAPEUTICS, INC. |
| CIK | 1434647 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (888) 958-1253 |